Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Preferred Stock Liabilities (2020 - 2025)

Historic Preferred Stock Liabilities for Marimed (MRMD) over the last 6 years, with Q3 2025 value amounting to $14.7 million.

  • Marimed's Preferred Stock Liabilities fell 2250.0% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year decrease of 2250.0%. This contributed to the annual value of $19.0 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Marimed's Preferred Stock Liabilities stood at $14.7 million, which was down 2250.0% from $14.7 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Preferred Stock Liabilities registered a high of $37.7 million during Q1 2021, and its lowest value of $14.7 million during Q1 2025.
  • Over the past 5 years, Marimed's median Preferred Stock Liabilities value was $21.9 million (recorded in 2023), while the average stood at $27.3 million.
  • As far as peak fluctuations go, Marimed's Preferred Stock Liabilities soared by 15619.69% in 2021, and later tumbled by 4963.55% in 2023.
  • Over the past 5 years, Marimed's Preferred Stock Liabilities (Quarter) stood at $37.7 million in 2021, then changed by 0.0% to $37.7 million in 2022, then tumbled by 49.64% to $19.0 million in 2023, then changed by 0.0% to $19.0 million in 2024, then fell by 22.5% to $14.7 million in 2025.
  • Its Preferred Stock Liabilities was $14.7 million in Q3 2025, compared to $14.7 million in Q2 2025 and $14.7 million in Q1 2025.